| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T657 |
0-128 |
Sentence |
denotes |
Scientists from all over the world are trying hard to develop working vaccines with robust protective immunity against COVID-19. |
| T658 |
129-506 |
Sentence |
denotes |
Vaccine candidates, like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus type 5 vector vaccine candidate (Ad5-nCoV), are a few examples under phase I clinical trials, while self-amplifying RNA vaccine, oral recombinant COVID-19 vaccine, BNT162, plant-based COVID-19 vaccine, and Ii-Key peptide COVID-19 vaccine are under preclinical trials (297). |
| T659 |
507-638 |
Sentence |
denotes |
Similarly, the WHO, on its official website, has mentioned a detailed list of COVID-19 vaccine agents that are under consideration. |
| T660 |
639-932 |
Sentence |
denotes |
Different phases of trials are ongoing for live attenuated virus vaccines, formaldehyde alum inactivated vaccine, adenovirus type 5 vector vaccine, LNP-encapsulated mRNA vaccine, DNA plasmid vaccine, and S protein, S-trimer, and Ii-Key peptide as a subunit protein vaccine, among others (298). |
| T661 |
933-1123 |
Sentence |
denotes |
The process of vaccine development usually takes approximately ten years, in the case of inactivated or live attenuated vaccines, since it involves the generation of long-term efficacy data. |
| T662 |
1124-1219 |
Sentence |
denotes |
However, this was brought down to 5 years during the Ebola emergency for viral vector vaccines. |
| T663 |
1220-1325 |
Sentence |
denotes |
In the urgency associated with the COVID-19 outbreaks, we expect a vaccine by the end of this year (343). |
| T664 |
1326-1575 |
Sentence |
denotes |
The development of an effective vaccine against COVID-19 with high speed and precision is the combined result of advancements in computational biology, gene synthesis, protein engineering, and the invention of advanced manufacturing platforms (342). |
